Preventing Superbugs and Protecting Patients Act
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to identify types of medical devices for which premarket notification must include proposed labeling, including validated instructions regarding cleaning, disinfection, and sterilization.
The FDA must issue final guidance regarding when a premarket notification is required for a modification to a medical device.| Action Date | Type | Text | Source |
|---|---|---|---|
| 2016-04-22 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2016-04-15 | IntroReferral | Referred to the House Committee on Energy and Commerce. | House floor actions |
| 2016-04-15 | IntroReferral | Introduced in House | Library of Congress |